These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35217267)

  • 1. Prefoldin and prefoldin-like complex subunits as predictive biomarkers for hepatocellular carcinoma immunotherapy.
    Zhao H; Chen C; Yang C; Mo S; Zhao H; Tian Y
    Pathol Res Pract; 2022 Apr; 232():153808. PubMed ID: 35217267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma.
    Ke S; Lu S; Wang C; Xu Y; Bai M; Yu H; Feng Z; Yin B; Li Z; Huang J; Li X; Qian B; Hua Y; Pan S; Wu Y; Ma Y
    Front Mol Biosci; 2022; 9():957001. PubMed ID: 36438659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prefoldin subunits (PFDN1-6) serve as poor prognostic markers in gastric cancer.
    Yesseyeva G; Aikemu B; Hong H; Yu C; Dong F; Sun J; Zang L; Zheng M; Ma J
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31957800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
    Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
    Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
    Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.
    Gu X; Guan J; Xu J; Zheng Q; Chen C; Yang Q; Huang C; Wang G; Zhou H; Chen Z; Zhu H
    J Transl Med; 2021 Jan; 19(1):26. PubMed ID: 33407546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
    Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
    World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry.
    Zhao N; Chen C; Guo Y; Liu T; Che N; Zhang D; Liang X; Zhang Y; Zhao X
    Dig Liver Dis; 2023 May; 55(5):661-672. PubMed ID: 36192339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma.
    Ding L; Yu Q; Yang S; Yang WJ; Liu T; Xian JR; Tian TT; Li T; Chen W; Wang BL; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    Front Immunol; 2022; 13():831101. PubMed ID: 35371079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma.
    Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L
    Dis Markers; 2022; 2022():2676114. PubMed ID: 35465267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The liquid-liquid phase separation signature predicts the prognosis and immunotherapy response in hepatocellular carcinoma.
    Wang Z; Wang G; Zhao P; Sun P
    J Cell Mol Med; 2024 Jul; 28(14):e18446. PubMed ID: 39072983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of immune-related target and prognostic biomarkers in PBMC of hepatocellular carcinoma.
    Hu R; Zhang W; Han Z; Ma M; Huang Q; Lv M; Ma W; Sun X; Feng W; Li J; Zhong X; Sun J; Yao W; Zhou X
    BMC Gastroenterol; 2023 Jul; 23(1):234. PubMed ID: 37438735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 17. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
    Cai J; Zhou M; Xu J
    World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
    Wang N; Zhou X; Tang F; Wang X; Zhu X
    Virchows Arch; 2021 Dec; 479(6):1153-1165. PubMed ID: 34448895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.